Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report issued on Monday. The firm issued a sell rating on the stock.

Streamline Health Solutions Price Performance

Shares of NASDAQ:STRM opened at $3.75 on Monday. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The stock has a market cap of $16.02 million, a PE ratio of -0.76 and a beta of 1.55. The stock’s fifty day simple moving average is $3.20 and its two-hundred day simple moving average is $4.69. Streamline Health Solutions has a 1-year low of $1.85 and a 1-year high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last released its quarterly earnings results on Monday, December 16th. The company reported ($0.61) earnings per share for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.